Tag: marketing

MELBOURNE, Australia, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Lumen has launched “The Talent Frontier,” a webcast series exploring innovative recruitment marketing and talent acquisition strategies to transform hiring. The inaugural session “AI for All: Rethinking Talent with Equity, Empathy & Automation,” sets the stage for diverse and inclusive topics in future sessions.

ROK Financial reports rising interest in flexible business lines of credit as small and mid-sized companies seek faster, more adaptable funding options in 2025.

Public interest in vitamin C has surged in 2025 as consumers search for cleaner, more effective options beyond standard pills. Across TikTok, Reddit, and wellness forums, questions are rising about ingredient sources, absorption rates, and the difference between synthetic ascorbic acid and real, whole-food vitamin C. NativePath Liposomal Vitamin C is positioned within this growing trend, featuring an amla-based 3-in-1 formula designed for nutrient integrity and advanced delivery. It reflects a broader shift toward transparency, clean sourcing, and solutions that align with evolving health and wellness priorities.

Public Interest in Natural Vertigo Support and Ingredient-First Balance Formulas Continues to Rise in 2025

Scientifically Formulated Nootropic Backed by 2025 Research for Sharper Focus and Cognitive Support

CALGARY, Alberta, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Condor Energies Inc. (“Condor” or the “Company”) (TSX:CDR), a Canadian based, internationally focused energy transition company focused on Central Asia is pleased to announce the release of its unaudited interim condensed consolidated financial statements for the three and six months ended June 30, 2025 (the “Financial Statements”), together with the related management’s discussion and analysis. These documents will be made available under Condor’s profile on SEDAR+ at www.sedarplus.ca and on the Condor website at www.condorenergies.ca. Readers are invited to review the latest corporate presentation available on the Condor website. All financial amounts in this news release are presented in Canadian dollars, unless otherwise stated.

AlphaCur Introduces Ingredient-First Nerve Health Formula as Interest in Neuropathy Support and Long-Term Wellness Grows in 2025

All amounts are stated in United States dollars unless otherwise indicated

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.

All figures are reported in United States dollars ($) unless otherwise indicated